David Andrew Sinclair AO (born June 26, 1969) is an Australian-American biologist and academic known for his research on aging and epigenetics. Sinclair is a professor of genetics at Harvard Medical School and is the co-director of its Paul F. Glenn Center for Biology of Aging Research. He is the president of the non-profit Academy for Health & Lifespan Research and an officer of the Order of Australia (AO).

Substances Taken by David A. Sinclair

Current

Substance Dose When
Nicotinamid Mononukleotid (NMN) 1000 mg Morning
Resveratrol 1000 mg Morning
Metformin 800 mg Night, not when he making excercise the next day and muscles are growing
Spermidine 1000 mg Morning
Quercetin 500 mg Morning
Fisetin 500 mg Morning
Vitamin D3 4,000 to 5,000 IUs
Vitamin K2 180 to 360 mcg
Low-Dose Aspirin 83 mg
Trimethylglycine (TMG) 500 - 1000 mg
Alpha Lipoic Acid (ALA) Recent status unknown
Coenzyme Q10 (coQ10) Recent status unknown

Previously

NMN Reseratrol Metformin Spermidine Quercetin Fisetin Vitamin D3 Vitamin K2 Low-Dose Aspirin TMG ALA coQ10
Lifespan: Why We Age – and Why We Don’t Have To Sept. 2019 x x x x x x
Interview Dec 2021 x x Morning
Podcast Jan 2022 x x Night x x x

Interviews and Podcasts

See also